| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 王班 | 民生证券 | 医药生物 | 42.70% | 46.13% | 33.33% | -21.43% | 15 | -61.25% | 2025-07-29 |
| 2 | 唐寅灏 | 中信证券 | 医药生物 | 42.67% | 40.13% | 24.29% | 60.00% | 12 | -8.47% | 2025-06-27 |
| 3 | 张林晚 | 上海证券 | 医药生物 | 42.62% | 39.63% | 32.72% | -100.00% | 1 | -18.93% | 2025-08-07 |
| 4 | 任晓帆 | 东海证券 | 医药生物 | 42.50% | 37.86% | 48.09% | 0.00% | 2 | -17.50% | 2025-08-12 |
| 5 | 夏禹 | 国联民生 | 医药生物 | 42.50% | 41.07% | 31.48% | 20.00% | 7 | -52.01% | 2025-05-22 |
| 6 | 叶思奥 | 光大证券 | 医药生物 | 42.48% | 34.35% | 47.97% | -60.00% | 3 | -47.18% | 2025-08-14 |
| 7 | 阳景 | 浦银国际证券 | 医药生物 | 42.47% | 46.06% | 20.16% | 100.00% | 3 | 0.00% | 2025-07-15 |
| 8 | 华挺 | 财通证券 | 医药生物 | 42.33% | 41.96% | 16.74% | -6.67% | 7 | -50.33% | 2025-07-31 |
| 9 | 张林晚 | 上海证券 | 医药生物 | 42.33% | 41.15% | 30.84% | -100.00% | 1 | -18.93% | 2025-08-12 |
| 10 | 万鹏辉 | 国海证券 | 医药生物 | 42.32% | 33.88% | 23.07% | 100.00% | 5 | 0.00% | 2025-08-14 |
| 11 | 仰佳佳 | 申万宏源 | 医药生物 | 42.32% | 44.69% | 39.86% | 16.67% | 1 | -37.64% | 2025-06-13 |
| 12 | 华挺 | 财通证券 | 医药生物 | 42.32% | 40.96% | 17.06% | -6.67% | 7 | -50.33% | 2025-08-13 |
| 13 | 刘浩 | 华创证券 | 医药生物 | 42.25% | 16.96% | -1.98% | 20.00% | 3 | -47.33% | 2024-12-31 |
| 14 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 42.17% | 43.39% | 44.63% | 3.45% | 1 | -27.10% | 2025-04-02 |
| 15 | 仰佳佳 | 申万宏源 | 医药生物 | 42.15% | 43.95% | 37.57% | 16.67% | 1 | -37.64% | 2025-06-16 |
| 16 | 华挺 | 财通证券 | 医药生物 | 42.11% | 41.74% | 16.56% | -6.67% | 7 | -50.33% | 2025-07-30 |
| 17 | 杨松 | 天风证券 | 医药生物 | 42.09% | -28.98% | 28.93% | -45.36% | 19 | -72.65% | 2025-08-04 |
| 18 | 仰佳佳 | 申万宏源 | 医药生物 | 42.08% | 45.19% | 31.49% | 16.67% | 1 | -37.64% | 2025-06-25 |
| 19 | 华挺 | 财通证券 | 医药生物 | 42.07% | 41.70% | 18.02% | -6.67% | 7 | -50.33% | 2025-07-29 |
| 20 | 唐寅灏 | 中信证券 | 医药生物 | 42.02% | 39.31% | 28.68% | 60.00% | 12 | -8.47% | 2025-06-24 |